导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.43% | 2600/4982 |
| 近一周 | -0.39% | 1724/5419 |
| 近一月 | -6.90% | 4758/5423 |
| 近一季 | 16.10% | 136/5376 |
| 近半年 | 2.17% | 1777/5131 |
| 近一年 | -17.26% | 4100/4741 |
| 近两年 | 44.87% | 2564/4208 |
| 近三年 | 24.60% | 2050/3661 |
| 成立以来 | 353.19% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.74% 963/5130 |
-4.52% 3813/5464 |
- - |
- - |
| 2025 | 38.24% 1589/5130 |
14.68% 292/4624 |
25.92% 31/4802 |
15.19% 3487/4970 |
-16.89% 4845/5130 |
| 2024 | -14.59% 3857/4618 |
-5.73% 2781/4340 |
-9.28% 3903/4442 |
11.00% 1969/4550 |
-10.03% 4265/4618 |
| 2023 | -2.86% 388/4216 |
5.37% 939/3759 |
-5.27% 2290/3909 |
-5.12% 1350/4055 |
2.58% 205/4209 |
| 2022 | -23.96% 1674/3578 |
-12.99% 580/2804 |
-4.64% 2770/3205 |
-15.34% 2433/3430 |
8.25% 325/3570 |
| 2021 | 7.56% 694/2717 |
-2.23% 649/1745 |
25.61% 170/2232 |
-5.16% 1228/2560 |
-7.65% 2260/2708 |
| 2020 | 75.05% 221/1596 |
12.85% 40/1036 |
41.78% 20/1256 |
1.17% 1148/1472 |
8.15% 1211/1690 |
| 2019 | 61.73% 103/926 |
30.30% 427/3054 |
1.03% 838/3201 |
18.84% 37/939 |
3.38% 879/1014 |
| 2018 | -19.88% 160/668 |
- - |
- - |
- - |
-16.33% 2788/2977 |
| 2017 | 22.56% 136/531 |
- - |
- - |
- - |
- - |
| 2016 | -22.85% 342/455 |
- - |
- - |
- - |
- - |
| 2015 | 53.02% 164/433 |
- - |
- - |
- - |
- - |
| 2014 | 2.26% 409/432 |
- - |
- - |
- - |
- - |
| 2013 | 33.75% 52/398 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 华宝医药生物混合A VS. 长安宏观策略混合A(740001) |